| Comparison of different methods for delineation of 18F-FDG PET–positive tissue for target volume definition in radiotherapy of patients with non–small cell lung cancer U Nestle, S Kremp, A Schaefer-Schuler, C Sebastian-Welsch, D Hellwig, ... Journal of nuclear medicine 46 (8), 1342-1348, 2005 | 817 | 2005 |
| 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis U Nestle, K Walter, S Schmidt, N Licht, C Nieder, B Motaref, D Hellwig, ... International Journal of Radiation Oncology* Biology* Physics 44 (3), 593-597, 1999 | 455 | 1999 |
| Prevention, diagnosis, therapy, and follow-up of lung cancer G Goeckenjan, H Sitter, M Thomas, D Branscheid, M Flentje, F Griesinger, ... Pneumologie 65 (01), 39-59, 2011 | 445* | 2011 |
| F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. R Bares, P Klever, S Hauptmann, D Hellwig, J Fass, U Cremerius, ... Radiology 192 (1), 79-86, 1994 | 305 | 1994 |
| Differentiated thyroid cancer—treatment: state of the art B Schmidbauer, K Menhart, D Hellwig, J Grosse International journal of molecular sciences 18 (6), 1292, 2017 | 253 | 2017 |
| F-18-FDG PET for mediastinal staging of lung cancer: Which SUV threshold makes sense? D Hellwig, TP Graeter, D Ukena, A Groeschel, GW Sybrecht, ... JOURNAL OF NUCLEAR MEDICINE 48 (11), 1761-1766, 2007 | 247 | 2007 |
| Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy O Sabri, EB Ringelstein, D Hellwig, R Schneider, M Schreckenberger, ... Stroke 30 (3), 556-566, 1999 | 238 | 1999 |
| Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy TP Graeter, D Hellwig, K Hoffmann, D Ukena, CM Kirsch, HJ Schäfers The Annals of thoracic surgery 75 (1), 231-236, 2003 | 197 | 2003 |
| Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease J Spiegel, D Hellwig, S Samnick, W Jost, MO Möllers, K Fassbender, ... Journal of neural transmission 114, 331-335, 2007 | 192 | 2007 |
| Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease J Spiegel, D Hellwig, MO Möllers, S Behnke, W Jost, K Fassbender, ... Brain 129 (5), 1188-1193, 2006 | 180 | 2006 |
| A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in … A Schaefer, S Kremp, D Hellwig, C Rübe, CM Kirsch, U Nestle European journal of nuclear medicine and molecular imaging 35, 1989-1999, 2008 | 178 | 2008 |
| Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms G Goeckenjan, H Sitter, M Thomas, D Branscheid, M Flentje, F Griesinger, ... Pneumologie 65 (08), e51-e75, 2011 | 165 | 2011 |
| Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer D Hellwig, A Gröschel, TP Graeter, AP Hellwig, U Nestle, HJ Schäfers, ... European journal of nuclear medicine and molecular imaging 33, 13-21, 2006 | 162 | 2006 |
| Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in … D Hellwig, D Ukena, F Paulsen, M Bamberg, CM Kirsch Pneumologie (Stuttgart, Germany) 55 (8), 367-377, 2001 | 156 | 2001 |
| Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma D Hellwig, TP Graeter, D Ukena, T Georg, CM Kirsch, HJ Schäfers The Journal of thoracic and cardiovascular surgery 128 (6), 892-899, 2004 | 137 | 2004 |
| 18F]-FOG-PET in clinical stage I and II non-seminomatous germ cell tumors: First results of the German Multicenter Trial. M De Wit, M Hartmann, J Kotzerke, M Wirth, W Brenner, D Hellwig, ... JOURNAL OF CLINICAL ONCOLOGY 23 (16), 379S-379S, 2005 | 133* | 2005 |
| FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer D Hellwig, RP Baum, CM Kirsch Nuklearmedizin-NuclearMedicine 48 (02), 59-69, 2009 | 128 | 2009 |
| Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease J Spiegel, D Hellwig, G Farmakis, WH Jost, S Samnick, K Fassbender, ... Movement disorders 22 (7), 1004-1008, 2007 | 121 | 2007 |
| Risk stratification of solitary pulmonary nodules by means of PET using 18F-fluorodeoxyglucose and SUV quantification A Grgic, Y Yüksel, A Gröschel, HJ Schäfers, GW Sybrecht, CM Kirsch, ... European journal of nuclear medicine and molecular imaging 37, 1087-1094, 2010 | 118 | 2010 |
| Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer U Nestle, A Schaefer-Schuler, S Kremp, A Groeschel, D Hellwig, C Rübe, ... European journal of nuclear medicine and molecular imaging 34, 453-462, 2007 | 113 | 2007 |
